Causal Hierarchy: Root Causes, Amplifiers, and Consequences

“The art of medicine consists in amusing the patient while nature cures the disease.”

— attributed to Voltaire

The art of understanding disease consists in distinguishing what nature is doing from what nature has done. Chapters Energy Metabolism and Mitochondrial Function through Speculative Mechanistic Hypotheses catalogue an imposing inventory of pathophysiological mechanisms in ME/CFS: mitochondrial dysfunction, immune dysregulation, neuroinflammation, endocrine disruption, cardiovascular impairment, gut dysbiosis, epigenetic modification, autoimmunity, ion channelopathy, and more. Chapter Integrative Models and Multi-System Pathophysiology demonstrated that these mechanisms interact rather than operate in isolation, and Chapter Symptom-Producing Mechanisms in ME/CFS distinguished capacity-limiting from symptom-producing pathways. What remains unanswered is the question of hierarchy: which of these mechanisms are causally sufficient to generate the full ME/CFS syndrome, which amplify and perpetuate it, and which are downstream consequences of the disease process?

This question is not academic. The causal hierarchy determines where therapeutic intervention is most likely to succeed, which research directions deserve priority, and why so many single-target treatments have disappointed. A treatment that addresses a downstream consequence cannot cure the disease; a treatment that targets an amplifier may reduce severity without enabling recovery; only interventions that release the trigger-capable mechanisms—or enough of the locks they establish—can plausibly restore health. The distinction between cause, amplifier, and consequence is therefore the single most important conceptual framework for rational treatment strategy in ME/CFS.

Yet the distinction is also profoundly difficult to make. In a disease characterized by bidirectional feedback loops, where immune dysfunction worsens energy metabolism which worsens immune function, the question “which came first?” can seem unanswerable. The framework developed in this chapter does not require answering that question for individual patients. Instead, it asks a different question: which mechanisms are capable of initiating the full cascade from a healthy baseline, and which require prior dysfunction to engage? This capability-based classification avoids the epistemic trap of reconstructing individual disease histories and instead focuses on the structural properties of each mechanism.

Before applying the classification, we must address a prior question that genetics has now answered: where is the constitutional vulnerability encoded? Three independent genetic evidence lines — common variant GWAS (DecodeME 2025, Maccallini 2026 meta-analysis, n=19,470), rare variant whole-exome sequencing (Snyder 2025), and cell-type enrichment analysis (Finucane 2018 pipeline across three brain atlases) — converge on a single answer: neuronal circuits. The genetic risk for ME/CFS maps to the brain — striatal medium spiny neurons, glutamatergic synapses, and broader brain-enriched pathways — with zero enrichment in any immune cell type (T cells, B cells, NK cells, macrophages; Section Three-Line Genetic Convergence on Neuronal Biology). The GWAS tells us where constitutional liability is encoded (neurons), not which mechanisms are operative in the established disease. This does not contradict the extensive evidence for immune dysfunction in ME/CFS — it reveals that immune pathology is acquired (infection-triggered, environmentally driven), with effect sizes below GWAS detection, rather than genetically encoded. The brain-first architecture constrains the upstream origin of vulnerability: the four trigger-capable root causes examined below all operate through or upon a neuronally vulnerable host. The triggers and amplifiers describe the downstream acquired pathology that propagates from that substrate. This is formalised in the two-hit model: genetic vulnerability in neuronal circuits (hit 1) + environmental trigger — viral infection, autoimmune activation, ion channel dysfunction (hit 2) → disease, with amplifiers sustaining chronicity.

The practical consequence for the causal hierarchy analysis that follows is that mechanisms with predominantly immune genetic architecture — classical autoimmunity, primary immunodeficiency, monogenic autoinflammatory disease — are structurally disfavoured as root causes. They may still operate as acquired triggers (GPCR autoantibodies, discussed below) or acquired amplifiers (NET/DNase imbalance, T-cell exhaustion), but the genetic architecture constrains their ability to explain why this patient and not that one from the same precipitant. The vulnerability is neuronal; the precipitant is environmental; the resulting immune pathology is acquired.

This chapter proposes a three-tier classification framework, applies it systematically to the mechanisms described in preceding chapters, and draws out the implications for treatment strategy and research design. The claims made here are themselves hypotheses—informed by evidence but not proven. The sister chapter in Part V (Chapter Formal Causal Hierarchy Analysis) tests these claims using formal mathematical models; the present chapter develops the biological reasoning that those models encode.

Note: How the Causal-Hierarchy Argument Flows

The causal-hierarchy thread spans three parts of this document. Four stations carry it from a qualitative classification to a formal test:

Station	Where	What it does	Part
1. Qualitative classification	Causal Hierarchy: Root Causes, Amplifiers, and Consequences	Classifies each mechanism as trigger-capable root cause, amplifier, or downstream consequence	Part II — this chapter
2. Registry entries	Hypothesis and Speculation Registry	Fielded records of every hypothesis with explicit certainty scores	Part IV
3. Proposed studies	Entries added 2026-08-26: Central Motor-Drive Fatigability Cascade (Bedard 2026)	Translates the registry hypotheses into testable research protocols	Part IV — ch47
4. Formal ODE test	Formal Causal Hierarchy Analysis	Tests tier assignments against the integrated ODE model using sensitivity and bifurcation analysis	Part V — ch56

Chapter Roadmap: How to Use This Chapter

For patients: read the three-tier framework to understand why many single treatments disappoint, and the root-cause sections (CNS energy crisis, safe mode) for what the causal story implies about recovery.

For caregivers: read the three-tier framework and the load-bearing-vs-secondary discussion to understand why treating consequences alone does not resolve the illness.

For clinicians: read the framework and the treatment-implications section — it explains why interventions that only address downstream consequences are unlikely to cure, and which mechanisms are candidates for root-cause targeting.

For researchers: read the four trigger-capable candidates and the research-implications section. These feed the formal tests in Chapter Formal Causal Hierarchy Analysis.

1 Contents